Viewing Study NCT05366166

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-02-20 @ 4:45 PM
Study NCT ID: NCT05366166
Status: RECRUITING
Last Update Posted: 2025-04-23
First Post: 2022-05-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pembrolizumab Plus Olaparib in LA-HNSCC
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Carcinoma of Head and Neck View
Keywords:

Keywords

Keyword Brief Keyword Text View
None head and neck View
None squamous cell carcinoma View
None HPV negative View
None pembrolizumab View
None olaparib View
None PARP inhibitor View
None anti-PD1 inhibitor View
None intensity modulation radiation therapy View
None Proton therapy View
None cisplatin View